FDA (Drugs) recall action 91259
The FDA (Drugs) publishes a recall like this one as 3 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 3 pages.
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
The agency’s own wording, quoted from the enforcement report.
The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.
Glaxosmithkline Consumer Healthcare is recalling Advil ibuprofen 200 mg tablets because adhesive migrated onto labels, causing them to tear when peeled. This affects 321,246 tablets distributed nationwide.
Glaxosmithkline Consumer Healthcare is recalling Advil Liqui Gels (minis) 200mg capsules nationwide due to illegible labeling caused by adhesive migration. Consumers should discard affected product or return it to the retailer.
Advil Liqui Gels (200mg ibuprofen capsules) are being recalled nationwide because adhesive on the packaging migrated onto the label, causing it to tear and become illegible when peeled back.